Stockscreener 앱 받기
6.26
1.29%
0.08
시간 외 거래:
6.28
0.02
+0.32%
전일 마감가:
$6.18
열려 있는:
$6.16
하루 거래량:
54,173
Relative Volume:
0.47
시가총액:
$75.77M
수익:
$57.70M
순이익/손실:
$11.98M
주가수익비율:
-10.89
EPS:
-0.5746
순현금흐름:
$-12.24M
1주 성능:
+10.21%
1개월 성능:
+13.00%
6개월 성능:
-47.53%
1년 성능:
-49.06%
1일 변동 폭
$6.1139
$6.47
1주일 범위
$5.59
$6.47
52주 변동 폭
$5.06
$13.47
Lensar Inc Stock (LNSR) Company Profile
명칭
Lensar Inc
전화
888-536-7271
주소
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
6.26 | 69.24M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-01 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-02-24 | 개시 | SVB Leerink | Outperform |
Lensar Inc 주식(LNSR)의 최신 뉴스
LENSAR (LNSR) Consolidates Near Support as Traders Eye Resistance at $6.11Box Spread - newsline.com
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
LENSAR Q1 earnings call highlights - MSN
(LNSR) Risk Channels and Responsive Allocation - Stock Traders Daily
LNSR Technical Analysis & ETF Price Forecast - Intellectia AI
LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings - Stock Titan
Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares - Stock Titan
LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer - Stock Titan
LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award - Stock Titan
LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years - Stock Titan
LENSAR (LNSR) director Aimee Weisner receives 17,421 RSUs as annual equity grant - Stock Titan
LENSAR (LNSR) director awarded 17,421 RSUs as annual stock compensation - Stock Titan
LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award - Stock Titan
LENSAR (LNSR) director receives 17,421 RSUs as annual equity award - Stock Titan
LENSAR, Inc. (LNSR) director receives 17,421 RSU equity grant - Stock Titan
LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3 - Stock Titan
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target - Yahoo Finance
Lensar Inc. Earnings Call Balances Recovery And Risk - The Globe and Mail
LENSAR Inc stock (US52633C1071): Q1 recurring revenue rose 9% - AD HOC NEWS
Lensar (LNSR) Q1 2026 Earnings Transcript - AOL.com
Lensar (LNSR) Q4 2025 Earnings Transcript - AOL.com
Lensar Reports First Quarter Fiscal 2026 Results; Management Highlights Strategic ProgressRevenue Inflection Point - newsline.com
Lensar (LNSR) Releases Q1 2026 Earnings Transcript: Key Insights for InvestorsGuidance Accuracy Score - The Legal Advocate
LENSAR Appoints Interim CFO, Accelerates Governance Timeline - The Globe and Mail
(LNSR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LENSARAppoints Michael A. Rossi As Interim CFO Effective May 29, 2026 - TradingView
[8-K] LENSAR, Inc. Reports Material Event - Stock Titan
LENSAR, Inc. Announces Appointment of Michael A. Rossi as Interim Chief Financial Officer, Effective May 29, 2026 - marketscreener.com
LENSAR Inc stock (US52633C1071): Q1 2026 update and valuation snapshot after volatile Nasdaq trading - AD HOC NEWS
LNSR Earnings Overview 2026-05-28Growth Acceleration Report - thelegaladvocate.com
LENSAR (LNSR) Stock Edges Lower Amid Modest Selling Pressure — Key Levels in FocusQuote Data - newsline.com
Lensar Stock Rallies Into Memorial Day Break — Why Tuesday’s Open Matters - Bez Kabli
LNSR Earnings Overview 2026-05-22Crowd Stock Picks - Newser
LENSAR Inc. (LNSR) Gains 1.2% as Shares Test Key Resistance ZoneVolume Rate Change - The Legal Advocate
LENSAR (LNSR) Up +3.57% — 3 Reasons the Rally Could Continue 2026-05-21Zero Gamma Level - Newser
LENSAR Inc stock (US52633C1071): FDA clearance for ALLY lowers capital requirements for eye surgeons - AD HOC NEWS
LENSAR (LNSR) Gains +1.38% — Support Holds at $5.59 2026-05-20Dark Pool Prints - Newser
Liquidity Mapping Around (LNSR) Price Events - Stock Traders Daily
What LENSAR (LNSR)'s +1.62% Jump Means for Investors 2026-05-18Community Pattern Alerts - Newser
LENSAR stock (US52633C1071): eye-surgery specialist back in focus after Alcon deal collapse - AD HOC NEWS
LENSAR Inc stock (US52634T1034): laser eye surgery specialist in focus after latest business updates - AD HOC NEWS
LENSAR signals 2027 as really, really good year as it rebuilds distributor orders after Alcon deal termination - MSN
Q1 2026 LENSAR Inc Earnings Call Transcript - GuruFocus
Brandes Investment Partners (NASDAQ: LNSR) holds 1.03M shares, 8.48% - Stock Titan
Earnings call transcript: LENSAR Q1 2026: EPS Miss, Stock Rises on Revenue Stability - Investing.com Nigeria
[144] LENSAR, Inc. SEC Filing - Stock Titan
All News for LNSR : LENSAR - Zacks Investment Research
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $10 - Moomoo
MSN Money - MSN
Lensar Inc (LNSR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lensar Inc 주식 (LNSR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| STAAB THOMAS R II | Chief Financial Officer |
Mar 19 '26 |
Option Exercise |
2.65 |
5,500 |
14,575 |
175,959 |
2.43%
자본화:
|
볼륨(24시간):